Citadel Advisors’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$531K Buy
15,900
+7,300
+85% +$271K ﹤0.01% 9153
2025
Q4
$299K Buy
8,600
+1,600
+23% +$59K ﹤0.01% 10162
2025
Q3
$262K Sell
7,000
-2,600
-27% -$89.9K ﹤0.01% 10662
2025
Q2
$312K Sell
9,600
-5,200
-35% -$149K ﹤0.01% 9723
2025
Q1
$399K Buy
14,800
+12,700
+605% +$373K ﹤0.01% 8976
2024
Q4
$60K Buy
2,100
+800
+62% +$23.3K ﹤0.01% 12178
2024
Q3
$35K Buy
1,300
+1,000
+333% +$26.3K ﹤0.01% 12289
2024
Q2
$8.33K Sell
300
-2,500
-89% -$68.1K ﹤0.01% 13196
2024
Q1
$77.4K Buy
2,800
+1,000
+56% +$26.1K ﹤0.01% 11700
2023
Q4
$43.9K Sell
1,800
-3,700
-67% -$84.1K ﹤0.01% 11917
2023
Q3
$123K Buy
+5,500
New +$133K ﹤0.01% 10632
2023
Q2
Sell
-7,700
Closed -$182K 14593
2023
Q1
$182K Buy
7,700
+3,800
+97% +$87.3K ﹤0.01% 10335
2022
Q4
$85.1K Buy
+3,900
New +$96.3K ﹤0.01% 11439
2022
Q3
Sell
-8,400
Closed -$226K 12912
2022
Q2
$226K Buy
8,400
+600
+8% +$19.3K ﹤0.01% 10441
2022
Q1
$305K Buy
+7,800
New +$303K ﹤0.01% 10552
2021
Q4
Sell
-8,600
Closed -$407K 14080
2021
Q3
$407K Sell
8,600
-1,500
-15% -$70.1K ﹤0.01% 10367
2021
Q2
$468K Buy
10,100
+2,200
+28% +$99.6K ﹤0.01% 10191
2021
Q1
$347K Buy
+7,900
New +$359K ﹤0.01% 10504

Other funds holding FFTY

Citadel Advisors's FFTY Position: Q1 2026 in Review

Citadel Advisors increased its CapForce IBD 50 ETF (FFTY) stake by 556% in Q1 2026, buying an estimated $1.28M and bringing the position to 40,706 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #6950.

Citadel Advisors first reported a position in FFTY in Q3 2015 and has held it in 33 quarters since. The position peaked at $3.97M in Q3 2021. 39 funds tracked by Wall St. Rank hold FFTY as of Q1 2026.

  • Citadel Advisors held 40,706 shares of CapForce IBD 50 ETF worth $1.36M as of Q1 2026.
  • Citadel Advisors bought 34,498 CapForce IBD 50 ETF shares in Q1 2026, an estimated $1.28M.
  • CapForce IBD 50 ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6950 holding.
  • Citadel Advisors first reported a position in CapForce IBD 50 ETF in Q3 2015 and has held it in 33 quarters since.
  • Citadel Advisors's CapForce IBD 50 ETF position peaked at $3.97M in Q3 2021.
  • 39 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.